Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel
Correspondence: Ronen Alon, Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel. Email: ronalon{at}wicc.weizmann.ac.il
|
|
|---|
Key Words: inflammation trafficking integrins G proteins
|
|
|---|
|
|
|---|
![]() View larger version (38K): [in a new window] |
Figure 1. Model for subsecond stimulation of VLA-4 clustering at adhesive
contacts by chemokine binding to integrin-associated GPCRs. Fast
changes in integrin clustering at short-lived adhesive contact zones
must occur to convert nonfunctional binding events into functional
tethers. An initial VLA-4VCAM-1 bond that is too weak to support a
functional tether (1) is followed by a local chemokine signal
transmitted through the chemokine GPCR (2). The G-protein signal
triggered by the GPCR is transmitted directly to the cytoplasmic tail
of a neighboring VLA-4 molecule or to an effector target near this
second VLA-4 (3). As a result, the mobility of the neighboring VLA-4 is
increased such that it can cluster at the site of initial bond
formation (4). A preformed GPCRVLA-4 complex is probably stabilized
within a raft domain on the tip of a leukocyte
microvillus._art>
|
4ß7, may be
segregated at these or other surface locations, within specific lipid
raft microdomains. Such domains are enriched with
heterotrimeric G proteins, integrin-associated tetraspannins, and Src
kinases, all putative modulators of integrin adhesiveness at dynamic
contacts [19
20
21
22
23
]. Because VLA-4 and LFA-1 are topographically segregated on the leukocyte surface, it is likely that each integrin is preferentially associated with a different subset of GPCRs capable of inducing its clustering. Consistent with this notion, chemokines can trigger reversible subsecond VLA-4 tethers to VCAM-1, which support lymphocyte capture and subsequent rolling interactions on VCAM-1-bearing surfaces, whereas chemokine-stimulated LFA-1 adhesion to intercellular-adhesion-molecule 1 (ICAM-1) results in irreversible adhesion and firm arrest [7 ]. Chemokine-triggered arrest is linked to augmentation of both LFA-1 clustering and binding affinity to ICAM-1 [10 ]. An interesting possibility is that the ability of VLA-4 to arrest lymphocytes on VCAM-1 might also be caused by high-affinity states preexistent on subsets of circulating lymphocytes [24 ]. However, VLA-4 affinity is internally controlled by the lymphocyte activation state [25 ] and is not modulated by chemokine [11 ]. Thus, to promote reversible leukocyte rolling, chemokine stimulation of VLA-4 should promote integrin adhesiveness without inducing high affinity to ligands. Chemokine stimulation of VLA-4-mediated rolling is consistent with the previously reported functional hierarchy of these integrins, indicating that VLA-4 adhesion precedes LFA-1 adhesion strengthening in various multistep, adhesive cascades of leukocytes on endothelial surfaces [26 ]. VLA-4 and LFA-1 are also differentially modulated by soluble chemokine signals. Whereas LFA-1 affinity and clustering can be triggered by soluble chemokines with similar efficiency to immobilized chemokines [10 ], VLA-4 fails to respond to such chemokines under physiological shear flow [11 ].
In another interesting finding, we demonstrated that subsecond signaling by chemokines does not involve Ca2+ mobilization from intracellular stores, phosphatidylinositol 3 (PI3)-kinase activity, or PTK activation [11 ]. Consistent with our results, chemokine-stimulation of LFA-1 affinity was also PI3-kinase independent and did not implicate a rise in intracellular free Ca2+, although the kinase was instrumental in LFA-1 mobility within the membrane and its polar patching on lymphocytes arrested on ICAM-1-bearing surfaces [10 ]. These relatively slow processes (>10 s) appeared therefore to contribute to LFA-1-mediated adhesion strengthening at a post-tethering level [10 ]. Thus, none of the classical effector systems triggered by chemokine signaling through GPCRs were necessary to promote rapid endothelial adhesion of lymphocytes mediated by either VLA-4 or LFA-1. Although Gi-protein activation of VLA-4 and LFA-1 adhesiveness has been linked to rapid stimulation of the guanosine triphosphatase RhoA [27 ], the role of this or other Rho-like guanosine triphosphatases in subsecond chemokine-induced VLA-4 clustering or in rapidly triggered LFA-1 affinity has not been demonstrated. It is possible that these rapid modulations of integrin activity are controlled by GPCR signaling to a subset of Rho, constitutively associated with preformed membranal-integrinGPCR complexes. We raise this hypothesis because Rho is a cytoplasmic protein [27 ], and therefore its recruitment to the membrane would be too slow to account for its putative role in triggering integrin avidity at subsecond adhesive zones.
|
|
|---|
Leukocytes generally move from their original site of arrest on the
endothelial surface to their site of diapedesis [36
].
Even if previously arrested at sites of diapedesis, the adherent
leukocyte must reorient its cell body and leading edge towards and
within the endothelial-migration zone. Because shear flow exerts
continuous disruptive forces on arrested leukocytes, these adhesive
processes must be carefully balanced to maintain migrating leukocyte
attachment to the vessel wall. Yet, at the same time, vascular
adherence must not exceed a level that would restrain leukocyte
spreading and locomotion to the site of diapedesis. Multiple
proadhesive and motility signals must therefore be transmitted in a
highly coordinated manner to the migrating leukocyte along its vascular
migratory path. The molecular basis of leukocyte spreading, locomotion,
and positioning at these endothelial sites of diapedesis under
continuous disruptive shear flow has been obscure. As a multistep
process, leukocyte TEM has been difficult to dissect in vivo or in
vitro under physiological shear-flow settings. The existence of
vascular endothelial models that lack endogenous chemokines for T
lymphocytes and can be reconstituted with specific chemokines
[16
] enabled us to use these models to dissect the
molecular basis of lymphocyte migration across vascular endothelium
under physiological shear flow. We used cytokine-activated endothelial
monolayers reconstituted with chemokines to dissect the steps by which
apical chemokine presentation promotes lymphocyte migration on and
across inflamed endothelium. The experimental set up illustrated in
Figure 2A
is based on individual cell tracking of freshly isolated
peripheral blood lymphocytes (PBLs) accumulated on a monolayer
of cytokine-activated primary ECs [tumor necrosis factor
(TNF)
-activated HUVECs] on which a chemokine of interest has been
overlaid. Both morphological changes and migratory properties of the
leukocytes adhering to the endothelial monolayers are monitored at a
single-cell level by phase-contrast videomicroscopy
[16
]. Analysis of leukocyte motion and shape is
conducted over a time scale of minutes, corresponding to in vivo
diapedesis processes of leukocytes extravasating at postcapillary
venules of lymphoid organs or inflamed peripheral tissues
[37
].
![]() View larger version (54K): [in a new window] |
Figure 2. Analysis of leukocyte TEM under physiological shear flow in a
parallel-plate flow chamber assay. The parallel-plate flow chamber
assay allowed us to resolve the separate steps in the migratory cascade
of leukocytes accumulating on an endothelial monolayer under shear flow
in the absence or presence of exogenous chemokine overlaid on the
apical surface of the monolayer. The indicated steps (i through vi)
were monitored by high-power videomicroscopy of all cells from their
initial accumulation in the field of view at low physiological flow (i)
until final diapedesis (vi): (i) rolling and arrest; (ii) detachment
from original site; (iii) spreading; (iv) firm stationary adhesion; (v)
locomotion over the ECs; (vi) transmigration through the ECs. The time
course of various parts of the assay, i.e., accumulation phase
and migration phase, are indicated. Below (B) are frames taken from
time-lapse digitized video recordings of lymphocytes adhered on
TNF- -activated HUVEC monolayers overlaid with SDF-1 (100 ng/mL) and
subjected to continuous shear stress of 5 dyn/cm2 for the
indicated period. Lymphocytes are numbered in a counterclockwise
manner, and numbers designate their central positions at
t = 0'. The paths traveled by each lymphocyte from
original point of arrest (t = 0') to final position
underneath or over the EC monolayer (t = 6') are
depicted with dashed lines and arrowheads. At t = 6',
lymphocytes 46 had completed TEM, whereas lymphocytes 13 moved
variable distances over the endothelial surface.
|
|
|
|---|
![]() View larger version (21K): [in a new window] |
Figure 3. Apical endothelial chemokines promote lymphocyte TEM under
physiological flow conditions. PBLs accumulated for 40 s at 0.75
dyn/cm2 on TNF- -stimulated (24 h, 2 ng/mL) HUVECs alone
or previously overlaid with SDF-1 (100 ng, 5 min) were subjected to
physiological shear stress (5 dyn/cm2) for 20 min. Cells
which remained bound to the ECs during the entire assay (cells per
field) were divided into three categories: arrested, "locomoting"
(without transmigration), and transmigrating (TEM; see Fig. 2
). For
inhibition of Gi-protein signaling, lymphocytes were incubated with
pertussis toxin. The fractions of PBLs of the total number of
accumulated lymphocytes that remained bound to the ECs during the
entire assay are indicated on top of each set of bars. The percentages
of TEM lymphocytes of initially accumulated lymphocytes are expressed
on top of the filled bars. Results shown are the means ±
SE of multiple independent experiments, i.e., using
different donors and EC preparations. * and ** stand for
P < 0.02 and 0.0001, respectively, compared with PBL
TEM across HUVECs without adsorbed SDF-1.
|
![]() View larger version (24K): [in a new window] |
Figure 4. Shear stress applied on adherent lymphocytes promotes TEM triggered by
apical chemokine. Lymphocytes accumulated for 40 s at 0.75
dyn/cm2 on SDF-1 overlaid TNF -activated HUVECs were
subjected for 15 min to shear stress of 5 dyn/cm2 or were
left in shear-free conditions. The fractions of transmigrating
lymphocytes of the originally accumulated lymphocyte population were
determined at the indicated time points. Results are the means ±
SE of five independent experiments. *, **, ***:
P < 0.05, 0.005, and 0.001 respectively, compared with
PBL TEM across HUVECs in the absence of shear flow.
|
|
|
|---|
![]() View larger version (64K): [in a new window] |
Figure 5. Leukocyte transmigration across endothelial and stromal barriers
requires distinct distribution patterns of chemokines. Under shear flow
conditions, leukocyte adhesion to the vascular endothelial barrier is
critically dependent on stimulation of leukocyte integrins by apical
endothelial chemokine(s) (open circles). These chemokines
alone or in conjunction with subendothelial chemokines (gray circles)
also promote rapid TEM under continuous-shear-flow conditions. In the
absence of shear flow, e.g., like in transstromal migration, leukocytes
may cross the stromal barrier only in response to a basal chemokine
(alone or when two distinct chemokines are sequentially displayed to
the migrating leukocyte on the apical and basal surfaces of the
barrier). Stimulation of shear-resistant leukocyte adhesion by apical
chemokines is not required in transstromal migration, in contrast to
its requirement in transendothelial migration. Although
leukocyte TEM is shown to take place through intercellular borders,
particular subsets of leukocytes may cross the endothelial lining by
traversing the venular endothelium through a transcellular route
[50
]. Relative hypothesized rates of lymphocyte
transmigration under these different experimental conditions are
summarized in the table below. EC, endothelial cells; ECM,
extracellular matrix; ST, stromal cells.
|
|
|
|---|
Chemokines are cationic proteins, which bind to heparan sulfate and related glycosaminoglycan moieties of endothelial or matrix proteoglycans [46 , 47 ]. The idea that juxtacrine signaling by immobilized chemoattractants may regulate adhesion and migration was first demonstrated for neutrophils interacting with inflamed endothelium [40 ]. Haptotaxis was suggested as an alternative migratory mechanism to chemotaxis by which cells move to a region of highest adhesiveness [48 ]. Our results strongly suggest that immobilized chemokines presented on adhesive endothelial surfaces act as haptotactic and juxtacrine regulatory elements in lymphocytes and possibly other leukocytes migrating on and through endothelial surfaces. An attractive possibility is that these haptotactic functions of chemokines are not restricted to endothelial surfaces and might contribute to leukocyte motility through the ECM barriers underlying the vessel wall. Although haptotactic migration has not been demonstrated in vivo, recent observations suggest that particular chemokines can drive directional lymphocyte migration across ECMs, even when uniformly presented in immobilized states on these matrices [49 ]. Thus, sublumenal chemokines deposited at the site of leukocyte extravasation (Fig. 5) may provide haptotactic and chemotactic signals that up-regulate both leukocyte adhesion and motility through the underlying basal lamina. Subsequently, gradients of locally secreted chemokines may navigate the migrating leukocyte through the ECM to its final destination in a chemotactic manner [45 ]. In conclusion, our studies suggest that chemokines, commonly suggested to act as mere chemoattractants [31 ] might transmit both proadhesive and promigratory signals to recruited lymphocytes in a nonchemotactic manner (i.e., independently of a gradient and not implicating the classical Gi-protein-triggered effector systems) [11 , 38 ]. Taken together, these new notions and the novel mechanoregulatory role we find for wall shear forces in promoting chemokine-triggered lymphocyte migration suggest that chemokine regulation of leukocyte trafficking is much more versatile than was previously realized.
Received December 30, 2000; revised April 4, 2001; accepted April 5, 2001.
|
|
|---|
This article has been cited by other articles:
![]() |
H. M. McGettrick, K. Hunter, P. A. Moss, C. D. Buckley, G. E. Rainger, and G. B. Nash Direct observations of the kinetics of migrating T cells suggest active retention by endothelial cells with continual bidirectional migration J. Leukoc. Biol., January 1, 2009; 85(1): 98 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Van de Walle, K. W. Jarosinski, and N. Osterrieder Alphaherpesviruses and Chemokines: Pas de Deux Not Yet Brought to Perfection J. Virol., July 1, 2008; 82(13): 6090 - 6097. [Full Text] [PDF] |
||||
![]() |
T. T. Murooka, R. Rahbar, L. C. Platanias, and E. N. Fish CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1 Blood, May 15, 2008; 111(10): 4892 - 4901. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Miles, E. Liaskou, B. Eksteen, P. F. Lalor, and D. H. Adams CCL25 and CCL28 promote {alpha}4{beta}7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1257 - G1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ghandour, X. Cullere, A. Alvarez, F. W. Luscinskas, and T. N. Mayadas Essential role for Rap1 GTPase and its guanine exchange factor CalDAG-GEFI in LFA-1 but not VLA-4 integrin mediated human T-cell adhesion Blood, November 15, 2007; 110(10): 3682 - 3690. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, K. D. Puri, J. M. Penninger, and P. Kubes Leukocyte PI3K{gamma} and PI3K{delta} have temporally distinct roles for leukocyte recruitment in vivo Blood, August 15, 2007; 110(4): 1191 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Smith, T. L. Deem, A. C. Bruce, J. Reutershan, D. Wu, and K. Ley Leukocyte phosphoinositide-3 kinase {gamma} is required for chemokine-induced, sustained adhesion under flow in vivo J. Leukoc. Biol., December 1, 2006; 80(6): 1491 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Shulman, R. Pasvolsky, E. Woolf, V. Grabovsky, S. W. Feigelson, N. Erez, Y. Fukui, and R. Alon DOCK2 regulates chemokine-triggered lateral lymphocyte motility but not transendothelial migration Blood, October 1, 2006; 108(7): 2150 - 2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Murooka, M. M. Wong, R. Rahbar, B. Majchrzak-Kita, A. E. I. Proudfoot, and E. N. Fish CCL5-CCR5-mediated Apoptosis in T Cells: REQUIREMENT FOR GLYCOSAMINOGLYCAN BINDING AND CCL5 AGGREGATION J. Biol. Chem., September 1, 2006; 281(35): 25184 - 25194. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-N. Chen, S.-F. Chang, P.-L. Lee, K. Chang, L.-J. Chen, S. Usami, S. Chien, and J.-J. Chiu Neutrophils, lymphocytes, and monocytes exhibit diverse behaviors in transendothelial and subendothelial migrations under coculture with smooth muscle cells in disturbed flow Blood, March 1, 2006; 107(5): 1933 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Mangan, D. O'Quinn, L. Harrington, C. S. Bonder, P. Kubes, D. F. Kucik, D. C. Bullard, and C. T. Weaver Both Th1 and Th2 Cells Require P-Selectin Glycoprotein Ligand-1 for Optimal Rolling on Inflamed Endothelium Am. J. Pathol., December 1, 2005; 167(6): 1661 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Curbishley, B. Eksteen, R. P. Gladue, P. Lalor, and D. H. Adams CXCR3 Activation Promotes Lymphocyte Transendothelial Migration across Human Hepatic Endothelium under Fluid Flow Am. J. Pathol., September 1, 2005; 167(3): 887 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hrecka, T. Swigut, M. Schindler, F. Kirchhoff, and J. Skowronski Nef Proteins from Diverse Groups of Primate Lentiviruses Downmodulate CXCR4 To Inhibit Migration to the Chemokine Stromal Derived Factor 1 J. Virol., August 15, 2005; 79(16): 10650 - 10659. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sela, R. Hershkoviz, L. Cahalon, O. Lider, and E. Mozes Down-Regulation of Stromal Cell-Derived Factor-1{alpha}-Induced T Cell Chemotaxis by a Peptide Based on the Complementarity-Determining Region 1 of an Anti-DNA Autoantibody via Up-Regulation of TGF-{beta} Secretion J. Immunol., January 1, 2005; 174(1): 302 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Rao, T. V. Betz, D. J. Lamont, M. B. Kim, S. K. Shaw, R. M. Froio, F. Baleux, F. Arenzana-Seisdedos, R. Alon, and F. W. Luscinskas Elastase Release by Transmigrating Neutrophils Deactivates Endothelial-bound SDF-1{alpha} and Attenuates Subsequent T Lymphocyte Transendothelial Migration J. Exp. Med., September 20, 2004; 200(6): 713 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hamon, E. Mbemba, N. Charnaux, H. Slimani, S. Brule, L. Saffar, R. Vassy, C. Prost, N. Lievre, A. Starzec, et al. A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1) Glycobiology, April 1, 2004; 14(4): 311 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Stanford and T. B. Issekutz The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo J. Leukoc. Biol., November 1, 2003; 74(5): 791 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. van Buul, C. Voermans, J. van Gelderen, E. C. Anthony, C. E. van der Schoot, and P. L. Hordijk Leukocyte-Endothelium Interaction Promotes SDF-1-dependent Polarization of CXCR4 J. Biol. Chem., August 8, 2003; 278(32): 30302 - 30310. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. van Wetering, N. van den Berk, J. D. van Buul, F. P. J. Mul, I. Lommerse, R. Mous, J.-P. t. Klooster, J.-J. Zwaginga, and P. L. Hordijk VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration Am J Physiol Cell Physiol, August 1, 2003; 285(2): C343 - C352. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Papayannopoulou, G. V. Priestley, H. Bonig, and B. Nakamoto The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization Blood, June 15, 2003; 101(12): 4739 - 4747. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Belnoue, M. Kayibanda, J.-C. Deschemin, M. Viguier, M. Mack, W. A. Kuziel, and L. Renia CCR5 deficiency decreases susceptibility to experimental cerebral malaria Blood, June 1, 2003; 101(11): 4253 - 4259. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shamri, V. Grabovsky, S. W. Feigelson, O. Dwir, Y. van Kooyk, and R. Alon Chemokine Stimulation of Lymphocyte alpha 4 Integrin Avidity but Not of Leukocyte Function-associated Antigen-1 Avidity to Endothelial Ligands under Shear Flow Requires Cholesterol Membrane Rafts J. Biol. Chem., October 11, 2002; 277(42): 40027 - 40035. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ali, S. J. Fritchley, B. T. Chaffey, and J. A. Kirby Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration Glycobiology, September 1, 2002; 12(9): 535 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Netelenbos, S. Zuijderduijn, J. van den Born, F. L. Kessler, S. Zweegman, P. C. Huijgens, and A. M. Drager Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells J. Leukoc. Biol., August 1, 2002; 72(2): 353 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Cuvelier and K. D. Patel Shear-dependent Eosinophil Transmigration on Interleukin 4-stimulated Endothelial Cells: A Role for Endothelium-associated Eotaxin-3 J. Exp. Med., December 10, 2001; 194(12): 1699 - 1709. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||